The relationship between CD8+ T cell accumulation within the tumor was also assessed by flow cytometry, which revealed a correlation of R2 = 0.48 (Supplemental section Figure S4) and confirmed the dose response effect elicited by BsAb therapy. Here, CD8A is linked to neoplasm.